Bioauxilium
Bioauxilium is a Quebec-based biotechnology company that designs, develops and manufactures THUNDER™ TR-FRET assay kits for quantifying cell signaling proteins and biomarkers, serving pharmaceutical, biotechnology, CRO and academic researchers globally through direct sales and a distributor network.
- Company typePrivate
- Founded2020
- HeadquartersMontréal, Canada
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bioauxilium does
Bioauxilium (BioAuxilium Research Inc.) is a privately held Quebec-based biotechnology company founded in 2020 that designs, develops, validates and manufactures ready-to-use THUNDER™ TR-FRET (Time-Resolved Förster Resonance Energy Transfer) assay kits for the drug discovery and life sciences research market. The company's proprietary THUNDER™ platform is a no-wash, homogeneous immunoassay technology that combines validated antibodies, proprietary Europium-chelate donor and far-red acceptor fluorophores, and optimized buffers to quantify low amounts of endogenous proteins in cells. Its catalog of 150+ kits and reagents spans cell signaling assays (phospho-proteins and transcription factors such as STAT, AKT, ERK, NF-kB), biomarker assays (human and mouse cytokines and chemokines), a cAMP assay for GPCR signaling, and supporting Toolbox Reagents.
Bioauxilium sells three core product families — THUNDER™ Cell Signaling Assay Kits, THUNDER™ Biomarker Assay Kits, and the THUNDER™ cAMP Assay Kit — in five kit sizes ranging from 100 to 10,000 assay points, with bulk order and lot reservation options. A complementary Custom Services offering covers antibody labeling (2–3 day turnaround), end-to-end custom assay development (4-phase workflow over 3–4 weeks), and on-demand custom kit manufacturing. The company targets drug discovery researchers at pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic laboratories, with one publicly disclosed enterprise user (Pfizer scientists using the THUNDER® Human CCL17 assay in published type 2 inflammation research).
The business operates a hybrid go-to-market: direct e-commerce and sales-team engagement in Canada and the United States, paired with a 20+ distributor network covering Europe, Asia (including an exclusive China partnership with Shanghai Universal Biotech), Oceania, the Middle East and Africa. Marketing is driven through technical content on bioauxilium.com, recurring presence at SLAS, ELRIG Drug Discovery and SDDN conferences, promotional discount programs (including a Lab Start-Up Program for new laboratories), and direct multilingual technical support delivered by the in-house scientific staff. Pricing is transactional and tiered by kit size, with no subscription or licensing model disclosed.
Bioauxilium firmographics
Firmographics- Name
- Bioauxilium
- Legal name
- BioAuxilium Research Inc.
- Website
- https://bioauxilium.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Bioauxilium is a Quebec-based biotechnology company that designs, develops and manufactures THUNDER™ TR-FRET assay kits for quantifying cell signaling proteins and biomarkers, serving pharmaceutical, biotechnology, CRO and academic researchers globally through direct sales and a distributor network.
- Ownership category
- akta.pro rank
Bioauxilium industry classification
Industry- Product category
- Life Sciences Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industries
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Cell-Based & Potency Assays (Bioassays) (HLAGADAH)
Keywords
Where Bioauxilium is headquartered
LocationHeadquarters
- HQ city
- Montréal
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Bioauxilium business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- TR-FRET Assay Kit Sales: Sale of ready-to-use THUNDER™ TR-FRET assay kits including Cell Signaling Assay Kits, Biomarker Assay Kits, cAMP Assay Kit, and Toolbox Reagents. Available in five sizes (100, 500, 2500, 5000, 10000 assay points). Bulk orders and lot reservation available.
- Custom Services: Custom antibody labeling services (2-3 day turnaround), custom assay development, and custom kit development. Turnaround time for custom assay development: 1 week (design), 1 week (feasibility), 1-2 weeks (development).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Kit sizes from 100 to 10,000 assay points |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Bioauxilium product offering
Product offeringCore offering
Bioauxilium designs, develops, validates, and manufactures the THUNDER™ TR-FRET platform — a portfolio of ready-to-use, no-wash homogeneous assay kits for profiling cell signaling pathways (phospho-proteins, transcription factors) and quantifying biomarkers such as cytokines and chemokines. The company also offers custom services including antibody labeling, custom assay development, and custom kit manufacturing for drug discovery and life sciences research customers. All kits are developed and produced in-house, sold in five sizes from 100 to 10,000 assay points.
Product overview
Bioauxilium offers the THUNDER™ TR-FRET platform, a portfolio of ready-to-use homogeneous (wash-free) TR-FRET assay kits and custom services for drug discovery and life sciences research. The core product line includes three assay kit categories — THUNDER™ Cell Signaling Assay Kits (for phospho-proteins and transcription factors), THUNDER™ Biomarker Assay Kits (for cytokines, chemokines, and other protein biomarkers), and the THUNDER™ cAMP Assay Kit (for GPCR signaling) — all built on the same proprietary no-wash TR-FRET technology. A complementary Toolbox Reagents offering extends the platform's flexibility. These assay products are supplemented by three custom service tiers: Custom Antibody Labeling (labeling customer antibodies with TR-FRET fluorophores), Custom Assay Development (full-service design-to-validation workflow), and Custom Kit Development (on-demand manufacturing of custom kit formulations). The company operates an in-house development and manufacturing operation ensuring lot-to-lot consistency, with over 140 kits and reagents developed since 2020.
Differentiator
Problem solved
Functional benefit
Brands
- THUNDER™: Proprietary TR-FRET assay platform and product line including cell signaling assay kits, biomarker assay kits, cAMP assay kits, and toolbox reagents for drug discovery research.
- THUNDER® Feedback Program
- Lab Start-Up Program
Products and services
- THUNDER™ TR-FRET Cell Signaling Assay Kits Fully validated cell-based assay kits that profile key cell signaling pathways (phospho-proteins and transcription factors) using a homogeneous wash-free TR-FRET immunoassay format; for pharma, biotech, CRO, and academic drug discovery researchers.
- THUNDER™ TR-FRET Biomarker Assay Kits Ready-to-use homogeneous TR-FRET kits for quantifying human and mouse cytokines, chemokines, and other biomarkers in cell culture supernatants using a two-site sandwich immunoassay format; for drug discovery and life sciences researchers.
- THUNDER™ cAMP TR-FRET Assay Kit Assay kit for quantifying cyclic AMP (cAMP) levels in cells using THUNDER™ TR-FRET technology, supporting GPCR signaling drug discovery applications.
- Custom Antibody Labeling Service Service that labels customer-provided antibodies with THUNDER™ TR-FRET fluorophores (Europium chelate donor or far-red acceptor), including buffer exchange, conjugation, purification, and certificate of analysis with 2–3 day turnaround.
- Custom Assay Development Service End-to-end custom TR-FRET assay development service with a multi-phase workflow (Design, Feasibility, Development) covering scientific consultation, antibody labeling, proof-of-concept, optimization, and fit-for-purpose validation over 3–4 weeks.
- Custom Kit Development On-demand manufacturing of custom assay kit formulations in small or bulk quantities following the custom assay development process, providing researchers with proprietary kits for their specific targets.
Quantifiable outcome
- LOD as low as 1 pg/mL for IL-1β and 6 pg/mL for IFNγ on PHERAstar FSX reader
- +2 more outcomes
Companies that use Bioauxilium
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Bioauxilium technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Bioauxilium partnerships and signals
Strategic signalPartnerships
22 partnerships are on record, tiered core and minor.
- Shanghai Universal Biotech Co., Ltd.coreExclusive distributor for China market. Located in Shanghai, China. Represents Bioauxilium's products in the Chinese market.
- tebubiocoreMulti-country distributor covering Belgium, France, Germany, Italy, Luxembourg, Netherlands, Portugal, Spain, and UK & Ireland. Provides comprehensive European coverage.
- Cayman Chemical CompanyminorUS-based distributor located in Ann Arbor, Michigan. Distributes Bioauxilium products in the US market.
- CedarlaneminorCanadian and US distributor with locations in Burlington, ON (Canada) and Burlington, NC (USA).
- 2BScientificminorDistributor covering Germany, UK and Ireland markets.
- RamconminorDistributor covering Denmark, Norway, Sweden, and Finland markets.
- ISOGENminorDistributor covering Luxembourg and Netherlands markets.
- LubioScienceminorSwiss distributor located in Zürich, Switzerland.
- ARPminorUS-based distributor in Waltham, MA.
- Sapphire North AmericaminorNorth America distributor in Ann Arbor, MI.
- ZagenominorUS-based distributor in Cambridge, MA.
- Szabo-ScandicminorAustrian distributor.
- 7BioScience GmbHminorGerman distributor in Neuenburg.
- IronMaas Consulting KftminorHungarian distributor in Budapest.
- Biotron HealthcareminorIndian distributor in Mumbai.
- KRISHGEN BioSystemsminorIndian distributor in Mumbai.
- ZOTALminorIsraeli distributor.
- AS ONE Co.minorJapanese distributor.
- Funakoshi Co.minorJapanese distributor.
- Truong BiominorVietnamese distributor in Ho Chi Minh City.
- 2NCBIOminorSouth Korean distributor.
- CHAYON LaboratoriesminorSouth Korean distributor.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Bioauxilium competitors and assessment
Company assessmentBroad incumbents
- Revvity (formerly PerkinElmer Life Sciences): Revvity owns the Cisbio HTRF (Homogeneous Time-Resolved Fluorescence) platform, the historical gold-standard TR-FRET technology that Bioauxilium's THUNDER™ competes against directly. They offer a vast catalog of HTRF kits, readers, and reagents across pharma and academic drug discovery.
- Bio-Techne (R&D Systems): Bio-Techne's R&D Systems brand sells ELISA, Luminex, and Simple Plex immunoassay kits for cytokine and biomarker quantification as well as phospho-protein assays. They overlap directly with Bioauxilium's biomarker kits and serve the same drug discovery and life science research customers.
- Promega: Promega offers a broad portfolio of cell-based assays including luminescent and fluorescence-based kits for pathway analysis (cAMP, GPCR, kinase). Their product range overlaps with Bioauxilium's cAMP and cell signaling kits in drug discovery applications.
- Bio-Rad Laboratories: Bio-Rad provides a wide range of life science research reagents, immunoassay kits, and instruments through their Life Science segment. Their offerings serve similar drug discovery and academic markets where Bioauxilium's kits are used.
- Thermo Fisher Scientific (LanthaScreen / Invitrogen): Thermo Fisher's LanthaScreen and Invitrogen TR-FRET/Terbium-based assay kits serve the same cell signaling and biomarker quantification workflows as Bioauxilium. Their scale, instrument integration, and global sales reach make them a primary incumbent competitor.
Regional players
- Eurofins Scientific: Eurofins DiscoverX offers cell-based assay kits and services (including enzyme fragments complementation/PathHunter) that compete with Bioauxilium's cell signaling offerings in drug discovery CRO applications, with stronger global CRO service integration.
Others
- Molecular Devices: Molecular Devices manufactures the SpectraMax multi-mode microplate readers that Bioauxilium validates its THUNDER™ assays on. As an instrument partner, they sit in the ecosystem but also have a complementary assay catalog of their own.
- BMG Labtech: BMG Labtech produces the PHERAstar microplate readers referenced in Bioauxilium's performance data. They are an enabling infrastructure provider in the TR-FRET assay ecosystem and offer some competing assay kits.
Direct peers
- Cell Signaling Technology (CST): CST offers the PathScan and AlphaLISA/ELISA-based phospho-protein and cytokine assay kits that compete head-to-head with Bioauxilium's THUNDER™ Cell Signaling and Biomarker kits. Both serve pharma and academic drug discovery researchers with validated phospho-protein detection assays.
- PerkinElmer (now Revvity) Cisbio brand legacy: Cisbio is the historical TR-FRET pioneer whose HTRF technology is now under Revvity. They are the most direct technology competitor to Bioauxilium's THUNDER™ platform, with a deeply entrenched pharma customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Bioauxilium social profiles
Digital presenceBioauxilium financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioauxilium leadership team
Management profileNumber of profiles
Profiles1 record
Bioauxilium funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioauxilium M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioauxilium
What does Bioauxilium do?
Bioauxilium designs, develops, validates, and manufactures the THUNDER™ TR-FRET platform — a portfolio of ready-to-use, no-wash homogeneous assay kits for profiling cell signaling pathways (phospho-proteins, transcription factors) and quantifying biomarkers such as cytokines and chemokines. The company also offers custom services including antibody labeling, custom assay development, and custom kit manufacturing for drug discovery and life sciences research customers. All kits are developed and produced in-house, sold in five sizes from 100 to 10,000 assay points.
Is Bioauxilium a public or private company?
Bioauxilium is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bioauxilium founded?
Bioauxilium was founded in 2020. It employs 1 to 10 people.
Where is Bioauxilium based?
Bioauxilium is headquartered in Montréal, Canada, in the North America region.
How does Bioauxilium make money?
Two revenue lines are on record. TR-FRET Assay Kit Sales are the primary driver. The others are custom Services.
Who are Bioauxilium's main competitors?
Broad incumbents on record are Revvity (formerly PerkinElmer Life Sciences), Bio-Techne (R&D Systems), Promega, Bio-Rad Laboratories and Thermo Fisher Scientific (LanthaScreen / Invitrogen). Eurofins Scientific is listed as a regional player. Others are Molecular Devices and BMG Labtech. Direct peers are Cell Signaling Technology (CST) and PerkinElmer (now Revvity) Cisbio brand legacy.
Does Bioauxilium have an API?
No public API is recorded for Bioauxilium.
What industry is Bioauxilium in?
Bioauxilium's product category is Life Sciences Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 325413 and its SIC code is 2835.